# EDGAR Filing Document

**Accession Number:** 0001580149
**File Stem:** 0001520138-25-000293
**Filing Date:** 2025-10
**Character Count:** 8538
**Document Hash:** acd45f3bd567ac5bf147adea9a62edb8
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001520138-25-000293.hdr.sgml**: 20251006

**ACCESSION NUMBER**: 0001520138-25-000293

**CONFORMED SUBMISSION TYPE**: POS EX

**PUBLIC DOCUMENT COUNT**: 14

**FILED AS OF DATE**: 20251006

**DATE AS OF CHANGE**: 20251003

**EFFECTIVENESS DATE**: 20251006

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BIOVIE INC.
- **CENTRAL INDEX KEY:** 0001580149
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 462510769
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** POS EX
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-288525
- **FILM NUMBER:** 251375259

**BUSINESS ADDRESS:**
- **STREET 1:** 680 W NYE LANE
- **STREET 2:** SUITE 201
- **CITY:** CARSON CITY
- **STATE:** NV
- **ZIP:** 89703
- **BUSINESS PHONE:** 775-888-3162

**MAIL ADDRESS:**
- **STREET 1:** 680 W NYE LANE
- **STREET 2:** SUITE 201
- **CITY:** CARSON CITY
- **STATE:** NV
- **ZIP:** 89703

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** NANOANTIBIOTICS, INC.
- **DATE OF NAME CHANGE:** 20130625

?xml version='1.0' encoding='ASCII'?

**As filed with the Securities and Exchange Commission on October 3, 2025.**

**Registration Statement No. 333-288525**

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**POST-EFFECTIVE AMENDMENT NO. 1**

**to**

**AMENDMENT NO. 3** **to**

**FORM S-1**

**REGISTRATION STATEMENT**

**UNDER**

**THE SECURITIES ACT OF 1933**

**BioVie Inc.**

*(Exact name of registrant as specified in its charter)*

 

---

| | | |
|:---|:---|:---|
| **Nevada** | **2834** | **46-2510769** |
| *(State or Other Jurisdiction of*<br> *Incorporation or Organization)* | *(Primary Standard Industrial*<br> *Classification Code Number)* | *(I.R.S. Employer*<br> *Identification Number)* |

---

**680 W Nye Lane, Suite 201**

**Carson City, NV 89703**

**(775) 888-3162**

*(Address, including zip code, and telephone number, including area code, of registrant's principal executive offices)*

**Cuong Do**

**Chief Executive Officer**

**c/o BioVie Inc.**

**680 W Nye Lane, Suite 201**

**Carson City, NV 89703**

**(775) 888-3162**

*(Name, address, including zip code, and telephone number,*

*including area code, of agent for service)*

*Copies to:*

 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Stephen E. Older, Esq.**<br> **Carly E. Ginley, Esq.**<br> **McGuireWoods LLP**<br> **1251 Avenue of the Americas**<br> **20th Floor**<br> **New York, NY 10020**<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(212) 548-2100**<br>

 

**Approximate date of commencement of proposed sale to the public**: From time to time after this registration statement becomes effective.

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933 check the following box: ☒

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐ Accelerated filer ☐ <br> Non-accelerated filer ☒ Smaller reporting company ☒ <br> Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

**This Post-Effective Amendment No. 1 shall become effective upon filing with the Securities and Exchange Commission in accordance with Rule 462(d) under the Securities Act of 1933, as amended.**

**EXPLANATORY NOTE**

BioVie Inc. (the "Company") previously filed with the Securities and Exchange Commission (the "SEC") a registration statement on Form S-1 (Registration No. 333-288525), which was declared effective by the SEC on August 7, 2025 (as amended, the "Registration Statement"). This Post-Effective Amendment No. 1 (this "Amendment") to the Registration Statement is being filed as an exhibits-only filing solely to include the consent of EisnerAmper LLP with respect to its report, dated August 15, 2025, relating to the financial statements of the Company contained in its Annual Report on Form 10-K for the fiscal year ended June 30, 2025, filed herewith as Exhibit 23.1. Accordingly, this Amendment consists only of the facing page, this explanatory note, Item 16 of Part II of the Registration Statement, the signature pages to the Registration Statement and Exhibit 23.1. The report of EisnerAmper LLP was filed in Prospectus Supplement No. 1, dated October 3, 2025, filed with the SEC pursuant to Rule 424(b)(3). The prospectus, as supplemented, and the balance of Part II of the Registration Statement are unchanged hereby and have been omitted.

**Part II**

**Information not required in prospectus**

**Item 16. Exhibits**

A list of the exhibits filed with this registration statement on Form S-1 is set forth on the Exhibit Index and is incorporated herein by reference.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | | **Incorporated by Reference** | **Incorporated by Reference** | **Incorporated by Reference** | **Incorporated by Reference** | **Incorporated by Reference** |
| <br>**Exhibit <br> No.** | <br>**Description** | **Form** | **File No.** | **Date Filed** | **Exhibit No.** | **Filed Herewith** |
| [23.1](bivi-posex1ex23z1.htm) | [Consent of EisnerAmper LLP](bivi-posex1ex23z1.htm) |  |  |  |  | [X](bivi-posex1ex23z1.htm) |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Act, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Carson City, State of Nevada, on October 3, 2025.

---

| | |
|:---|:---|
| **BIOVIE INC.** | **BIOVIE INC.** |
| By: | /s/ Cuong Do |
|  | Cuong Do |
|  | President and Chief Executive Officer |
|  | (Principal Executive Officer) |

---

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.

---

| | | |
|:---|:---|:---|
| **Signature** | **Title** | **Date** |
| /s/ Cuong Do | President and Chief Executive Officer, Director | October 3, 2025 |
| Cuong Do | (Principal Executive Officer) |  |
| \* | Chief Financial Officer | October 3, 2025 |
| Joanne Wendy Kim | (Principal Financial Officer and Principal Accounting Officer) |  |
| \* | Chairman of the Board of Directors | October 3, 2025 |
| Jim Lang |  |  |
| \* | Director | October 3, 2025 |
| Sigmund Rogich |  |  |
| \* | Director | October 3, 2025 |
| Michael Sherman |  |  |

---

---

| | | |
|:---|:---|:---|
| \* | By:&nbsp;&nbsp;&nbsp;&nbsp; | /s/ Cuong Do |
|  |  | Cuong Do<br> Attorney-In-Fact |

---

## Exhibit 23.1

Exhibit 23.1

**CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**

We consent to the inclusion in the prospectus supplement to the Registration Statement of BioVie Inc. on Form S-1 (No. 333-288525) to be filed on or about October 3, 2025, of our report dated August 15, 2025, on our audits of the financial statements as of June 30, 2025 and 2024 and for each of the years then ended. Our report includes an explanatory paragraph about the existence of substantial doubt concerning the Company's ability to continue as a going concern.

/s/ EISNERAMPER LLP

Iselin, New Jersey

October 3, 2025